Volume 8 Issue 6
Nov.  2017
Turn off MathJax
Article Contents

doi: 10.3969/j.issn.1674-7445.2017.06.015
  • Received Date: 2017-08-21
    Available Online: 2021-01-19
  • Publish Date: 2017-11-15
  • loading
  • [1]
    李猛, 盛宏霞, 张斌, 等. 脐血来源造血干细胞体外培养扩增技术研究进展[J/CD]. 中华细胞与干细胞杂志(电子版), 2016, 6(2): 127-133. DOI: 10.3877/cma.j.issn.2095-1221.2016.02.010.

    Li M, Sheng HX, Zhang B, et al. Study progress of ex vivo expansion of human cord blood hematopoietic stem cell[J/CD]. Chin J Cell Stem Cell(Electr Edit), 2016, 6(2): 127-133. DOI: 10.3877/cma.j.issn.2095-1221.2016.02.010.
    [2]
    马锡慧, 肖漓, 石炳毅, 等. 间充质干细胞免疫抑制作用及其在移植免疫中应用的研究进展[J/CD]. 中华细胞与干细胞杂志(电子版), 2015, 5(1): 42-47. DOI: 10.3877/cma.j.issn.2095-1221.2015.01.009.

    Ma XH, Xiao L, Shi BY, et al. Research advance in immunosuppressive action and application of mesenchymal stem cells in transplantation immunity[J/CD]. Chin J Cell Stem Cell(Electr Edit), 2015, 5(1): 42-47.DOI: 10.3877/cma.j.issn.2095-1221.2015.01.009.
    [3]
    Sheng H, Wang Y, Jin Y, et al. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1[J]. Cell Res, 2008, 18(8): 846-857. DOI: 10.1038/cr.2008.80.
    [4]
    Sharpe AH, Wherry EJ, Ahmed R, et al. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection[J]. Nat Immunol, 2007, 8(3): 239-245. DOI: 10.1038/ni1443.
    [5]
    杨柳, 朱曦龄, 黎功, 等.程序性死亡因子配体1在肝细胞癌中的表达及意义[J].临床肝胆病杂志, 2016, 32(8): 1630-1634. DOI: 10.3969/j.issn.1001-5256.2016.08.047.

    Yang L, Zhu XL, Li G, et al. Expression of programmed death-ligand 1 in hepatocellular carcinoma and its clinical significance[J]. J Clin Hepatol, 2016, 32(8): 1630-1634. DOI: 10.3969/j.issn.1001-5256.2016.08.047.
    [6]
    倪勋, 贾永前, 孟文彤, 等.B7-H1在人骨髓间充质干细胞上的表达及其对T淋巴细胞增殖的影响[J].中国实验血液学杂志, 2009, 17(4): 990-993. http://d.wanfangdata.com.cn/Periodical/zgsyxyxzz200904032

    Ni X, Jia YQ, Meng WT, et al. Expression of B7-H1 molecule on human bone marrow mesenchymal stem cells and its effects on T lymphocyte proliferation[J]. J Exp Hematol, 2009, 17(4): 990-993. http://d.wanfangdata.com.cn/Periodical/zgsyxyxzz200904032
    [7]
    Chen Y, Chen S, Liu LY, et al. Mesenchymal stem cells ameliorate experimental autoimmune hepatitis by activation of the programmed death 1 pathway[J]. Immunol Lett, 2014, 162(2 Pt B): 222-228. DOI: 10.1016/j.imlet.2014.10.021.
    [8]
    Luz-Crawford P, Noël D, Fernandez X, et al. Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway[J]. PLoS One, 2012, 7(9): e45272. DOI: 10.1371/journal.pone.0045272.
    [9]
    Wang WB, Yen ML, Liu KJ, et al. Interleukin-25 mediates transcriptional control of PD-L1 via STAT3 in multipotent human mesenchymal stromal cells (hMSCs) to suppress Th17 responses[J]. Stem Cell Reports, 2015, 5(3): 392-404. DOI: 10.1016/j.stemcr.2015.07.013.
    [10]
    Chinnadurai R, Copland IB, Patel SR, et al. IDO-independent suppression of T cell effector function by IFN-gamma-licensed human mesenchymal stromal cells[J]. J Immunol, 2014, 192(4): 1491-1501. DOI: 10.4049/jimmunol.1301828.
    [11]
    Yan Z, Zhuansun Y, Chen R, et al. Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism[J]. Exp Cell Res, 2014, 324(1): 65-74. DOI: 10.1016/j.yexcr.2014.03.013.
    [12]
    Yan Z, Zhuansun Y, Liu G, et al. Mesenchymal stem cells suppress T cells by inducing apoptosis and through PD-1/B7-H1 interactions[J]. Immunol Lett, 2014, 162(1 Pt A): 248-255. DOI: 10.1016/j.imlet.2014.09.013.
    [13]
    Wang H, Qi F, Dai X, et al. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin[J]. Transpl Immunol, 2014, 31(2): 65-74. DOI: 10.1016/j.trim.2014.06.005.
    [14]
    Gu YZ, Xue Q, Chen YJ, et al. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells[J]. Hum Immunol, 2013, 74(3): 267-276. DOI: 10.1016/j.humimm.2012.12.011.
    [15]
    Wang G, Zhang S, Wang F, et al. Expression and biological function of programmed death ligands in human placenta mesenchymal stem cells[J]. Cell Biol Int, 2013, 37(2): 137-148. DOI: 10.1002/cbin.10024.
    [16]
    王国艳, 王斐斐, 李恒, 等.表达PD-L1/PD-L2的人胎盘间充质干细胞对外周血T细胞分泌IL-17的拮抗作用[J].细胞与分子免疫学杂志, 2013, 29(2): 132-136. http://kns.cnki.net/KCMS/detail/detail.aspx?filename=xbfm201302006&dbname=CJFD&dbcode=CJFQ

    Wang GY, Wang FF, Li H, et al. PD-L1/PD-L2 on human placenta-derived mesenchymal stem cells inhibits the IL-17 secretion of peripheral blood T cells[J]. Chin J Cell Mol Immunol, 2013, 29(2): 132-136. http://kns.cnki.net/KCMS/detail/detail.aspx?filename=xbfm201302006&dbname=CJFD&dbcode=CJFQ
    [17]
    王炜玮, 李恒, 徐逢皇, 等.γ干扰素上调人胎盘间充质干细胞PD-L1表达并增强其诱导脐血和外周血T细胞向IL-10+ T细胞的分化[J].细胞与分子免疫学杂志, 2016, 32(2): 191-195. http://kns.cnki.net/KCMS/detail/detail.aspx?filename=xbfm201602011&dbname=CJFD&dbcode=CJFQ

    Wang WW, Li H, Xu FH, et al. IFN-gamma up-regulates PD-L1 expression in human placenta mesenchymal stem cells and enhances cell ability to induce the differentiation of IL-10+ T cells from cord blood-and peripheral blood-derived T cells[J]. Chin J Cell Mol Immunol, 2016, 32(2): 191-195. http://kns.cnki.net/KCMS/detail/detail.aspx?filename=xbfm201602011&dbname=CJFD&dbcode=CJFQ
    [18]
    Tipnis S, Viswanathan C, Majumdar AS. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO[J]. Immunol Cell Biol, 2010, 88(8): 795-806. DOI: 10.1038/icb.2010.47.
    [19]
    Jang IK, Yoon HH, Yang MS, et al. B7-H1 inhibits T cell proliferation through MHC class Ⅱ in human mesenchymal stem cells[J]. Transplant Proc, 2014, 46(5): 1638-1641. DOI: 10.1016/j.transproceed.2013.12.059.
    [20]
    Pan Q, Fouraschen SM, Kaya FS, et al. Mobilization of hepatic mesenchymal stem cells from human liver grafts[J]. Liver Transplant, 2011, 17(5): 596-609. DOI: 10.1002/lt.22260.
    [21]
    de Mare-Bredemeijer EL, Mancham S, Verstegen MM, et al. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses[J]. Stem Cells Dev, 2015, 24(12): 1436-1447. DOI: 10.1089/scd.2014.0485.
    [22]
    Wu W, Lan Q, Lu H, et al. Human amnion mesenchymal cells negative co-stimulatory molecules PD-L1 expression and its capacity of modulating microglial activation of CNS[J]. Cell Biochem Biophys, 2014, 69(1): 35-45. DOI: 10.1007/s12013-013-9763-9.
    [23]
    Yoo KH, Jang IK, Lee MW, et al. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues[J]. Cell Immunol, 2009, 259(2): 150-156. DOI: 10.1016/j.cellimm. 2009.06.010.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (165) PDF downloads(16) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return